Prostate News Archive
10-Apr-2007
PSA Is Poor Predictor Of Lethal Prostate Cancer (Medical News Today)
The amount of prostate-specific antigen (PSA) in a man's bloodstream at the time of his prostate cancer diagnosis or its rate of change over the course of the disease does not adequately predict lethal prostate cancer, according to a study in the April 4 Journal of the National Cancer Institute. [click link for full article] PSA doubling predicts prostate cancer recurrence (EurekAlert!)
A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy. PSA Doubling Predicts Prostate Cancer Recurrence (Science Daily)
A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy. In a new Mayo Clinic study, the concept of PSA doubling time is found to be a reliable tool to distinguish which patients have prolonged innocuous PSA levels after therapy from those who are at great risk for disease recurrence and death from prostate cancer. ...
Back to Prostate News Archive
